全文获取类型
收费全文 | 2565篇 |
免费 | 78篇 |
国内免费 | 80篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 94篇 |
妇产科学 | 16篇 |
基础医学 | 166篇 |
口腔科学 | 41篇 |
临床医学 | 295篇 |
内科学 | 937篇 |
皮肤病学 | 4篇 |
神经病学 | 74篇 |
特种医学 | 44篇 |
外科学 | 83篇 |
综合类 | 211篇 |
预防医学 | 142篇 |
眼科学 | 9篇 |
药学 | 458篇 |
2篇 | |
中国医学 | 112篇 |
肿瘤学 | 33篇 |
出版年
2023年 | 78篇 |
2022年 | 107篇 |
2021年 | 117篇 |
2020年 | 116篇 |
2019年 | 121篇 |
2018年 | 102篇 |
2017年 | 69篇 |
2016年 | 74篇 |
2015年 | 67篇 |
2014年 | 236篇 |
2013年 | 178篇 |
2012年 | 158篇 |
2011年 | 175篇 |
2010年 | 131篇 |
2009年 | 128篇 |
2008年 | 111篇 |
2007年 | 117篇 |
2006年 | 76篇 |
2005年 | 83篇 |
2004年 | 48篇 |
2003年 | 28篇 |
2002年 | 40篇 |
2001年 | 28篇 |
2000年 | 27篇 |
1999年 | 33篇 |
1998年 | 21篇 |
1997年 | 20篇 |
1996年 | 11篇 |
1995年 | 19篇 |
1994年 | 27篇 |
1993年 | 8篇 |
1992年 | 18篇 |
1991年 | 15篇 |
1990年 | 8篇 |
1989年 | 4篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1986年 | 11篇 |
1985年 | 10篇 |
1984年 | 11篇 |
1983年 | 9篇 |
1982年 | 10篇 |
1981年 | 12篇 |
1980年 | 8篇 |
1979年 | 7篇 |
1978年 | 5篇 |
1977年 | 8篇 |
1976年 | 7篇 |
1975年 | 4篇 |
1973年 | 4篇 |
排序方式: 共有2723条查询结果,搜索用时 15 毫秒
991.
Zhuolun Song Nan Ma Chong Dong Chao Sun Xingchu Meng Wei Zhang Kai Wang Bin Wu Shanni Li Hong Qin Chao Han Haohao Li Wei Gao Zhongyang Shen 《Journal of pediatric surgery》2019,54(11):2382-2386
BackgroundDonors with low-body-weight were previously reported to be related to inferior recipient outcomes in pediatric liver transplantation. However, the scarce availability of age and size-matched organs has encouraged us to re-evaluate the feasibility and safety of using low-body-weight donors.MethodsWe retrospectively analyzed 91 deceased donor pediatric liver transplantation between January 2014 and December 2016, donor weight less than 5 kg was defined as low-body-weight donors. The recipients were divided into two groups according to donor weight.(≤ 5 kg and 5 kg < to ≤ 20 kg). Donor and recipient characteristics, perioperative data, postoperative complications as well as graft and recipient survival rate were comparedResultsThe recipients and grafts recovery after transplantation were comparable between two groups. The recipients receiving low-body-weight donors showed higher risk of hepatic artery thrombosis and small-for-size syndrome, however, these complications can effectively be treated by our strategies. The 2-year patient survival rates were 92.9% and 95.2%, 2-year graft survival rates were 92.9% and 93.7% in Groups 1 and 2, without significant difference.ConclusionsOur finding suggested that the utility of livers from low-body-weight donors is a potential strategy to increase donor availability in well-selected pediatric recipients.Level of EvidenceIII 相似文献
992.
目的采用相关可视化的方法,探讨壮骨关节丸(Zhuangguguanjie Wan,ZGW)特异质肝损伤指标丙氨酸转氨酶(ALT)与27种细胞因子的相关性。方法 SD大鼠禁食12 h后,ig给予ZGW 3.8 g/kg,2 h后尾iv 2.8 mg/kg的脂多糖(LPS),给予LPS 10 h后水合氯醛麻醉大鼠,下腔静脉取血,采集肝组织样本。检测血清中ALT活力及肝脏组织27种细胞因子水平。R 3.2.4软件分析ALT与27种细胞因子及27种细胞因子之间的相关性。结果 ALT与巨噬细胞炎性蛋白1α(MIP-lα)和血管内皮生长因子(VEGF)之间具有较强的正相关性,白细胞介素-18(IL-18)、趋化因子-10(IP-10)、IL-1α和IL-1β之间具有很强的相关性,嗜酸性粒细胞趋化因子(eotaxin)或调节活化正常T细胞表达和分泌的趋化因子(RANTES)各自具有独立性。结论 ZGW特异质肝损伤与MIP-1α和VEGF之间具有较强的正相关性,为ZGW临床安全用药及风险防控提供新的实验证据。 相似文献
993.
994.
995.
996.
Claret G Noguera A González-Cuevas A García-García JJ Fortuny C Muñoz-Almagro C 《European journal of pediatrics》2008,167(9):991-994
GB virus C (GBV-C) is a blood-borne flavivirus. The prevalence of GBV-C viremia among healthy adults is 0.5% to 4% and, to date, no disease has been definitely associated with GBV-C infection. We conducted a cross-sectional study to evaluate GBV-C viremia prevalence in a group of 327 healthy children with normal alanine amino transferase (ALT) levels (Group A) and elevated ALT levels (Group B) of unknown origin, and among 38 pediatric patients with mother-to-child-transmitted hepatitis C virus (HCV) infection (Group C). No statistically significant differences were observed between prevalences in Groups A and B (2.2% vs 6.7%, p = 0.06). None of the children in Groups A or B who tested positive for GBV-C RNA showed any clinical symptoms. The prevalence of GBV-C viremia in Group A was lower than for patients in Group C (2.2% vs 13.2%, p = 0.007); no differences were observed in HCV infection characteristics between those patients who were co-infected with GBV-C and those who were not. In conclusion, while GBV-C viremia is more frequent among HCV-infected pediatric patients, it is neither associated with liver disease nor has any influence on HCV-related chronic hepatitis. 相似文献
997.
目的: 了解大学新生乙型肝炎(乙肝)病毒感染情况,为校园内乙肝的防治提供科学依据。方法: 采集蚌埠医学院2009级3 120名新生清晨空腹静脉血,分别采用酶联免疫法、改良赖氏法、重氮法测定乙肝表面抗原(HBsAg)、丙氨酸氨基转移酶(ALT)和总胆红素(TBIL)。结果: 3 120名新生中,HBsAg阳性99名,阳性率为3.17%;男、女生HBsAg阳性率分别为3.77%和2.82%,差异无统计学意义(P>0.05)。男、女生ALT异常率和TBIL异常率差异有统计学意义(P<0.01),ALT、TBIL异常者中男女生HBsAg阳性率差异无统计学意义(P>0.05)。结论: 新生HBsAg携带率比社会人群的HBsAg携带率低,对有HBsAg阳性的学生应加强管理,对易感人群进行乙肝疫苗接种,防止乙肝在学校传播。 相似文献
998.
Jianqi Zeng Feng Chen Yiqian Chen Muli Peng Xingyu Chen Qingwei Yang Ru Wang Jiayin Miao 《Medicine》2021,100(37)
For patients with ischemic stroke, intravenous (IV) thrombolysis with Urokinase within 6 hours has been accepted as beneficial, but its application is limited by high risk of hemorrhagic complications after thrombolysis. This study aimed to analyze the risk factors of hemorrhagic complications after intravenous thrombolysis using Urokinase in acute cerebral infarction (ACI) patients.Total 391 consecutive ACI patients were enrolled and divided into 2 groups: the hemorrhagic complications group and the non-hemorrhagic complications group. The related data were collected and analyzed.Univariate analysis showed significant differences in prothrombin time, atrial fibrillation (AF), Mean platelet volume, large platelet ratio (L-PLR), triglyceride (TG), Lactate dehydrogenase, alanine aminotransferase (ALT), high-density lipoprotein, and baseline National Institute of Health Stroke Scale score between the hemorrhagic complications and the non-hemorrhagic complications group (P < .1). Multivariate logistic regression analysis indicated that AF (odds ratio [OR] = 2.91, 95% confidence interval [CI] = 1.06–7.99 P = .039) was the risk factor of hemorrhagic complications, while ALT (OR = 0.27, 95% CI = 0.10–0.72 P = .009) and TG (OR = 0.16, 95% CI = 0.06–0.45 P = .000) were protective factors of hemorrhagic complications.For patients with AF and lower levels of ALT or TG, the risk of hemorrhagic complications might increase after ACI. 相似文献
999.
1000.
罗氏Modular全自动生化分析仪酶学指标检测性能验证 总被引:2,自引:0,他引:2
目的验证罗氏Modular全自动生化分析仪酶学指标丙氨酸氨基转移酶(ALT)和天门冬氨酸氨基转移酶(AST)分析性能。方法根据美国临床实验室标准化研究所(CLSI)系列文件(EP5-A2、EP15-A2、EP6-A2、EP7-A2、C28-A2)和其他相关文献的实验方案,对罗氏Modular全自动生化分析仪检测A坍、AST的精密度、准确度、线性、临床可报告范围、干扰和生物参考区间6大性能进行验证,并与厂商声明的性能或公认的质量标准进行比较。结果精密度均符合罗氏性能标准;对卫生部5份室间质控品检测结果与靶值的相对偏倚(SE%)在-3.94%--9.09%之间,变异指数得分(VIS)均〈50,室内质控(IQC)结果与罗氏全球质控系统(Qcs)结果相对SE%在-3.70%~5.85%之间;ALT、AST检测均呈一次线性(r=0.999,P〈0.05),线性范围分别为4~1332U/L、4~1031U/L;ALT、AST的临床可报告范围分别为0~133200U/L和0~206200U/L;血红蛋白(Hb)对AST检测有正干扰,Hb≤6.025g/L的干扰效应剂量曲线呈一次线性(P〈0.05);ALT、AST生物参考区间验证结果均在本实验室给出的参考区间内。结论罗氏Modular生化分析仪ALT、AST检测的主要分析性能符合质量目标要求,CLSI实验评价方案具有可操作性和实用性。 相似文献